Livingstone M, Rosen G, Drislane F, et al.Physiological and anatomical evidence for a magnocellular defect in developmental dyslexia. Proc Natl Acad Sci USA1991;88:7943-7947.
2.
Jenner AR, Rosen GD, Galaburda AM. Neuronal asymmetries in primary visual cortex of dyslexic and nondyslexic brains. Ann Neurol1999;46:189-196.
3.
Genain C, Cannella B, Hauser S, Raine C.Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat Med1999;5:153-154.
4.
Raine CS, Cannella B, Hauser SL, Genain CP. Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: a case for antigen-specific antibody mediation. Ann Neurol1999;46:144-160.
5.
Dierks T, Lindan DEJ, Jandl M, Formisano E, Goebel R, Lanfermann H, et al.Activation of Heschl’s gyrus during auditory hallucinations. Neuron1999;22:615-621.
6.
Schacher S, Wu F, Panyko JD, Sun Z-Y, Wang D.Expression and branch-specific export of mRNA are regulated by synapse formation and interaction with specific postsynaptic targets. J Neurosci1999;19:6338-6347.
7.
Finnerty GT, Langdon SER, Connors BW. Sensory experience modifies the short-term dynamics of neocortical synapses. Nature1999;400:367-371.
8.
Whistler JL, Chuang H, Chu P, Jan LY, von Zastrow M.Functional dissociation of μ opioid receptor signaling and endocytosis: implications for the biology of opiate tolerance and addiction. Neuron1999;23:737-748.
9.
Doetsch F, Caille I, Lim DA, Garcia-Verdugo JM, Alvarez-Buylia A.Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell1999;97:703-716.
10.
Damier P, Hirsch EC, Agid Y, Graybiel AM. The substantia nigra of the human brain I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D immunohistochemistry. Brain1999;122:1421-1436.
11.
Damier P, Hirsch EC, Agid Y, Graybiel AM. The substantia nigra of the human brain II. Patterns of loss of dopamine-containing neurons in Parkinson’s disease. Brain1999;122:1437-1448.
12.
Saper CB. ‘Like a thief in the night’: the selectivity of degeneration in Parkinson’s disease. Brain1999;122:1401-1402.